Profile of Buparlisib and Its Potential in the Treatment of Breast Cancer: Evidence to Date [Corrigendum]

Breast Cancer: Targets and Therapy - New Zealand
doi 10.2147/bctt.s166117
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

Profile of Abemaciclib and Its Potential in the Treatment of Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2018English

Evidence to Date: Ranibizumab and Its Potential in the Treatment of Retinopathy of Prematurity

Eye and Brain
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2019English

Cryoablation in the Management of Breast Cancer: Evidence to Date

Breast Cancer: Targets and Therapy
Oncology
2019English

Palbociclib: An Evidence-Based Review of Its Potential in the Treatment of Breast Cancer

Breast Cancer: Targets and Therapy
Oncology
2014English

Profile of Crizanlizumab and Its Potential in the Prevention of Pain Crises in Sickle Cell Disease: Evidence to Date

Journal of Blood Medicine
Hematology
2019English

Spotlight on Siponimod and Its Potential in the Treatment of Secondary Progressive Multiple Sclerosis: The Evidence to Date

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Profile of Sarilumab and Its Potential in the Treatment of Rheumatoid Arthritis

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Up-To-Date Surgery and the Treatment of Cancer

BMJ
1905English

Clinical Potential of Brodalumab in the Management of Psoriasis: The Evidence to Date

Psoriasis: Targets and Therapy
DermatologyRheumatology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy